Company Data
INmune Bio Inc.
Ticker
INMB
Current Price
$2.24 -2.61%
Market Cap
$62.2M
Price Target
Refer to Report
Volume
205.3K
52wk Range
$1.09 - $2.499
Overview
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient’s innate immune system to allow the immune system to fight cancer. The company’s pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.